Sunday, March 6, 2011

Traditional drug-discovery model ripe for reform

Academic researchers set to play much greater role in pharmaceutical development.

Daniel Cressey 

The kit may have improved, but the in-house drug discovery model has HULTON–DEUTSCH/CORBIS
changed relatively little.HULTON–DEUTSCH/CORBIS

With drug pipelines running dry and a slew of blockbuster medicines about to lose patent protection, the voices arguing that the traditional drug-development process is too expensive and inefficient to survive are getting louder.

Source and/or read more:

 Publisher and/or Author and/or Editor:__Andres Agostini ─ @Futuretronium at Twitter! Futuretronium Book at